FGF23 as a calciotropic hormone [version 1; referees: 2 approved]

Abstract

Maintaining mineral metabolism requires several organs and hormones. Fibroblast growth factor 23 (FGF23) is a phosphatonin produced by bone cells that reduces renal production of calcitriol – 1,25(OH)2D3 – and induces phosphaturia. The consequences of a reduction in 1,25(OH)2D3 involve changes in calcium homeostasis. There are several factors that regulate FGF23: phosphorus, vitamin D, and parathyroid hormone (PTH). More recently, several studies have demonstrated that calcium also modulates FGF23 production. In a situation of calcium deficiency, the presence of 1,25(OH)2D3 is necessary to optimize intestinal absorption of calcium, and FGF23 is decreased to avoid a reduction in 1,25(OH)2D3 levels.

Keywords

• Anemias & Hypocellular Marrow Disorders
• Bone & Mineral Metabolism
• Cardiovascular Physiology/Circulation
• Dialysis & Renal Transplantation
• Endocrinology
• Mineral Metabolism & the Kidney
• Pathophysiology of Chronic Kidney Disease (CKD)
• Renal Pharmacology